Running head: AGENCY REPORT 1

Rosalyn Scotland
Agency Report
Wilington !ni"ersity
Running head: AGENCY REPORT #
Mission
PRA $ealth Sciences% pro"iding inno"ati"e solutions &or our clients is 'hat 'e do( Side)
*y)side 'ith our clients% 'e stri"e to o"e drug disco"ery &or'ard% helping the to de"elop li&e)
sa"ing and li&e)ipro"ing drugs( With our uni+ue *lend o& e,pertise% 'e pro"ide coprehensi"e
clinical de"elopent ser"ices across all phases( -ro &ull ser"ice clinical de"elopent to the
pioneering E*edded Solutions

odel% PRA or CRO .clinical research organi/ation0 pro"ides a
*road spectru o& solutions that eet the deands o& a di"erse ar1etplace(
The 2usiness 3e"elopent tea is responsi*le &or pursuing opportunities &or long)ter
gro'th &ro e,isting custoers% prospecti"e custoers and ar1ets( The tea 'or1s to *uild
and le"erage relationships &ounded on trust and integrity and the "alues o& our core
essage4*rand to &acilitate opportunities &or PRA5s gro'th and longe"ity(
Demographics
PRA $ealth Sciences is a glo*al copany( Currently the organi/ation eployee5s
appro,iately 16%666 sta&& across the glo*e( O&&ices are located all across North Aerica% South
Aerica% 7iddle East% A&rica% Asia Paci&ic% Europe .central4eastern4'estern0( The current census
'ould *e 869 &eales and 169 ales( Age% race% nationality and ethic orientation "ary( PRA
$ealth Sciences is still gro'ing 'ithin this industry and continues to see1 a di"erse sta&& to
ser"ice the di"erse population it ser"ices(
Within y departent% 7s( Ale,andra Poulos anages a sta&& consisting o& 8:9 &eales
and :9 ales( Although &eales doinate sta&&ing eergence% Caucasians are the doinant race
'ithin this area( What ; ha"e &ound to *e interesting 'ith y site anager% she is 1669 in"ol"ed
'ith each sta&& e*er and ta1es her ne' hires to lunch during their &irst 'ee1 to gain
1no'ledge and insight to their &uture endea"ors(
Running head: AGENCY REPORT <
PRA $ealth Sciences ser"ices a di"erse population( The target population "aries in age%
race% creed and color( =argely *ecause o& the ser"ice pro"ided% our clients can *e as young as 16
years o& age or as old as 86 years o& age(
Policies and Procedures
Policies and procedures are supplied to each sta&& through coputeri/ed trainings( The
policies and procedures are adinistered *y the sponsoring copany and PRA $ealth Sciences(
Each procedure has *een put in place to aintain con&identiality% con&lict o& interest% and
copliance la's 'ith the ;nstitutional Re"ie' 2oard .;R20% 'or1 place sa&ety% records
anageent and harassent(
The &irst responsi*ility is to the doctors% nurses and patients 'ho use the products and
ser"ices( PRA *elie"es they are here to eet the needs o& those they ser"e 'ith the highest
+uality and standards( !pholding the procedures that ha"e *een put in place has pro"ided this
organi/ation gro'th &inancially and 'ith their relationship 'ith other agencies(
Structure
ReSearch Pharaceutical Ser"ices .RPS0 'as *rought *y its current o'ners PRA
;nternational( A cross)&unctional integration tea consisting o& RPS and PRA e,ecuti"es has
*een hard at 'or1 to de&ine the processes and organi/ational structure that 'ill &or the *asis &or
our co*ined *usiness going &or'ard( They ha"e de&ined the &uture)state structure and
leadership &or all o& the &unctions o& the *usiness( These organi/ational structure decisions ha"e
*een ipleented and 'or1 has *egun to integrate underlying *usiness processes( They *elie"e
that the structure that has *een created ena*les the to capitali/e on the strengths o& *oth
organi/ations to create a po'er&ul plat&or to dri"e pro&ita*le gro'th &or the *usiness o"ing
&or'ard(
Running head: AGENCY REPORT >
2elo' is a description o& the PRA E,ecuti"e 7anageent Tea as 'ell as the leaders o&
the E*edded Solutions Tea( The e*edded solutions di"ision is contracted *y ?anssen a
sponsoring copany( The E*edded Solutions di"ion has *een designed to erge clinical
operations% anageent and in&rustructure and support of PRA and our sponsor
partner to create a cost-efective integrated outsourced operating model.
Corporate Executive Team
President and CEO @ Colin Shannon
EAP and C-O @ =inda 2addour
EAP% Corporate Copliance O&&icer ) 3a"id 3oc1horn
EAP% Early 3e"elopent Ser"ices @ Wille ?an 3riB&hout
EAP% Glo*al 2usiness 3e"elopent @ Tai Clerr)Nai"ar
President% RPS Strategic Solutions 3i"ision @ $arris Co&&er
EAP% Product Registration EAPA @ Sean =eech
EAP% Clinical ;n&oratics and =ate Phase Ser"ices @ Ste"e Po'ell
EAP% Product Registration Aericas @ Andy Strayer
COO% RPS Strategic Solutions 3i"ision @ Sair Shah
EAP% Therapeutic E,pertise @ Cent Thoel1e
Embedded Solutions Team
G74Senior 3irector @ Nicole 3u&&ey
3irector @ 2ill Gallagher
3irector o& Site 7anagers .S7s0 @ Patt Repu1as
7anager ) ?ill 3orey
7anager ) 2enBain Cos1o
7anager ) Tiothy Gal"in
7anager ) Ale,andra Poulos
7anager ) Anne Anders
Governance
PRA is operated *y the president and CEO Colin Shannon( Colin and the e,ecuti"e tea
a1e decisions that a&&ect sta&&% client and sponsoring copanies( As a top &i"e Clinical Research
Organi/ation .CRO0% the e,ecuti"e tea aasses a 'ealth o& 1no'ledge spanning 'ell o"er 166
years collecti"ely( PRA makes its fnancial information and reports available to holders
of our Senior Notes and to any benefcial oners of the Senior Notes! as ell as any
prospective investors! securities analysts or market makers.
Running head: AGENCY REPORT :
Funding
PRA $ealth Sciences is &unded *y the a'ards granted &ro the agencies 'ho utili/e their
ser"ices( PRA &or the &irst t'o +uarters ha"e *een a'arded &unds &ro Gilead &or D1E illion%
7ed ;une &or D<F illion and 2oston Scienti&ic &or D> illion and D#F illion pending
appro"al( These and other copanies *elie"e in the product and ser"ice that PRA o&&ers and are
leaders in their areas o& e,pertise(
Within the pharaceutical industry% clinical research organi/ations *rea1 do'n into t'o
prograsG e*edded and &ull ser"ice( PRA is a &ull ser"ice organi/ation that is a*le to anage
any areas o& clinical research( E*edded progras are the portions o& PRA $ealth Sciences5
that 'or1 'ith sponsor copanies( To gain 'or1ing appro"al% PRA ust *id &or the contract in
the &or o& a Re+uest &or Proposal .R-P0( Ters are identi&ied and i& the R-P is granted% a'ard
dollars are gi"en(
Relationship to other Agencies
PRA $ealth Sciences has a&&iliation 'ith o"er t'enty agencies( These sponsors pro"ide
ser"ices to thousands o& those participating in clinical trials and research( Sponsoring copanies
are: ;ncyte% $ani% ?anssen Pharaceutical Copanies o& ?ohnson H ?ohnson% Agen% Te"a
No"artis P&i/er and Astra Ieneca to nae a &e'( These agencies pro"ide the &unding and
assistance needed to run clinical trials(
Strengths Trends and Challenges
As a top &i"e CRO% PRA $ealth Sciences has 'or1ed on 166J ar1eted drugs across
se"eral therapeutic areas and conducted the pi"otal or supporti"e trials that led to -3A and4or
international regulatory appro"al o& >:J such drugs( PRA is on the cutting edge o& technology
and leading other CRO5s( PRA understands the need to a,ii/e success 'hile inii/ing tie
Running head: AGENCY REPORT F
and costs( They ha"e de"eloped an e&&icient and po'er&ul process that deonstrates their
coitent to e,ecuting studies under short tielines(
Another strength &or PRAG PRA is the only copany in the industry to o&&er a
strategically scala*le% &ully)e*edded solution( The E*edded Solutions odel is designed to
erge clinical operations e,pertise% anageent% in&rastructure% and support o& PRA and our
sponsor partner to create a cost)e&&ecti"e integrated outsourced operating odel( The E*edded
Solutions odel inii/es the resource spi1ing that occurs 'ithin de"elopent progras%
increasing resource utili/ation and signi&icantly decreasing costs 'hile our sponsors aintain
strategic control(
!ntern"s Role
7y role as an intern consists o& e assisting y site anager 'ith eeting inutes%
docuent% lead group discussions and o*ser"ing one to one consultations( Currently ; a
'or1ing to ipro"e y clinical and pharaceutical 1no'ledge and learn the copany5s policies
and procedures( 7y anager has a&&orded e the opportunity to learn systes and progras to
input and retrie"e data(
;n conclusion% PRA $ealth Sciences 'ould *e an e,cellent copany to 'or1 &or and to
e,cel in *ecoing a anager( There is a 'ealth o& 1no'ledge here and roo &or ad"anceent( ;&
you are 'illing to per&or at your highest le"el and are not a&raid o& ad"enture% PRA ay *e &or
you(
Running head: AGENCY REPORT E
Re#erences
PRA $ealth Sciences% Retrie"ed ?une #>% #61> http:44'''(prahs(co4solutions4strategic)
solutions